Johnson & Johnson’s Janssen Pharmaceuticals unit is facing a growing number of Levaquin lawsuits filed on behalf of patients throughout the United States who claim to have suffered an aortic aneurysm, peripheral neuropathy (nerve damage) and other potentially life-altering injuries while taking the controversial fluoroquinolone antibiotic medication. If you believe you or a loved one has suffered aortic aneurysm or aortic dissection injuries from Levaquin, or another potentially defective medication, our consumer advocates at the Consumer Justice Foundation can help. We are dedicated to protecting the rights of consumers harmed by dangerous pharmaceutical drugs, and we can help put you in touch with a product liability lawyer who has experience handling Levaquin aortic aneurysm claims.
Many people experiencing a bacterial infection, skin infection or another type of infection assume that taking an antibiotic medication is the only way to effectively fight the infection and relieve the associated symptoms. However, there are actually a number of natural treatment options that may be beneficial in helping with certain types of bacterial infections and skin infections, without the use of potentially dangerous antibiotic drugs, including the following:
August 15, 2013 – The FDA publishes new warnings about the potential for Levaquin to cause possibly irreversible peripheral neuropathy in users within 72 hours of starting treatment.
November 19, 2014 – The FDA receives two petitions from consumers who raise concerns about the lack of Levaquin label warnings regarding the risk of psychiatric side effects and mitochondrial toxicity.
August 7, 2015 – Experts urge the FDA to add a risk of mitochondrial toxicity to the warning label for Levaquin and other medications belonging to the same class of antibiotics.
December 2001 – A study published in The Annals of Pharmacotherapy finds a possible link between the use of fluoroquinolone antibiotics like Levaquin and peripheral neuropathy side effects.
September 6, 2013 – Research involving 90,000 patients with diabetes taking Levaquin and Cipro suggests that diabetics using oral fluoroquinolone antibiotics have an increased risk of severe dysglycemia, a term that refers to abnormalities in blood glucose levels.
March 13, 2014 – A study published in the medical journal Annals of Family Medicine indicates that patients taking Levaquin have a 2.4-times increased risk of experiencing cardiac arrhythmia, and a 2.5-times increased risk of death in the first five days of treatment.
August 25, 2014 – The medical journal Neurology publishes research finding a two-fold increased risk of peripheral neuropathy side effects associated with the use of fluoroquinolone antibiotics like Levaquin.
February 9, 2015 – A case report involving a Massachusetts woman indicates that she used a generic version of the antibiotic Levaquin for just nine days, and subsequently suffered severe nerve damage.
March 27, 2015 – A North Carolina woman believes that side effects of Levaquin caused her to suffer severe nerve damage and other injuries, and is pushing to get the medication pulled from the market.
November 2015 – Research published in the British Medical Journal indicates that patients taking fluoroquinolone antibiotics like Levaquin may be three times more likely to suffer an aortic aneurysm.
November 2015 – JAMA Internal Medicine publishes a study linking fluoroquinolones to a two-times increased risk of dissection and aneurysm within 60 days of using the medications.
Every year, millions of people are administered Levaquin, either in oral or intravenous form, and many of these people are unaware of the potential for the antibiotic drug to cause aortic aneurysm, peripheral neuropathy and other major side effects in users. Experts, however, have been aware of the risks of fluoroquinolones since at least 2001, when one study of 45 cases of peripheral neuropathy found an association between fluoroquinolone antibiotics and “severe, long-term adverse effects involving the peripheral nervous system as well as other organ systems.” Unfortunately, Janssen Pharmaceuticals has failed to provide consumers and the medical community with adequate warnings about the dangers of fluoroquinolones, and product liability lawsuits brought against Janssen in recent years allege the following:
Patients expect antibiotic medications like Levaquin to treat their infection or other medical problem without putting them at risk for unnecessary injuries. However, studies have shown that patients taking Levaquin or another drug in the fluoroquinolone class of antibiotics may be at risk for devastating and potentially irreversible side effects like peripheral neuropathy, aortic aneurysm or aortic dissection. As more information comes to light about the risk of health problems from Levaquin, a growing number of product liability lawsuits are expected to be brought against Janssen Pharmaceuticals, on behalf of injured patients nationwide. If you took Levaquin in the past, and you have since suffered from peripheral neuropathy, aortic aneurysm or another serious side effect, contact a reputable Levaquin attorney today for legal help.